Mateo S. Andrade Mier

Mateo S. Andrade Mier

Auto-generated profile, based on publicly available information

Mateo S. Andrade Mier

Institute for Clinical Neurobiology University Hospital of Würzburg Würzburg Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2025 in Advanced Healthcare Materials
Verified
Journal Article
Open access
NMNicoletta Murenu
Nicoletta Murenu
CMCamilla Mussoni
Camilla Mussoni
MMMateo S. Andrade Mier
Mateo S. Andrade Mier
PBPaula Buettner
Paula Buettner
NCNathaly Chicaiza-Cabezas
Nathaly Chicaiza-Cabezas
NSNatascha Schäfer
Natascha Schäfer
Bioprinting technology has attracted significant attention in the field of tissue engineering, enabling the precise placement of cells, biomaterials, and biomolecules to construct 3D tissue and organ structures. This review explores the feasibility of bioprinting functional organs by assessing current advancements in the field. A poll conducted among people from diverse backgrounds reveals common optimism regarding the future of organ bioprinting and its role in medicine and other fields. The article is conceptualized from a student‐to‐student perspective to provide a brief overview of key aspects of bioprinting, including bioinks, crosslinking techniques, bioprinting methods, and the maturation process required to develop functional tissues. Furthermore, it highlights recent progress in printing specific tissues as models for studying healthy and diseased tissues as well as implantable grafts. While there are still significant challenges that require the integration of technologies from engineering, biomaterials science, cell biology, physics, and medicine, ongoing research continues to address these complexities. The possibilities of bioprinting tissues and organs go beyond minimizing dependence on animal testing and advancing drug discovery; indeed, this approach also opens the door to accessible personalized medicine and presents a viable solution to the worldwide organ donor shortage.

15 February 2026 in Advanced Healthcare Materials
Verified
Journal Article
Open access
NMNicoletta Murenu
Nicoletta Murenu
ETEsra Tuerker
Esra Tuerker
AWAnna‐Lena Wiessler
Anna‐Lena Wiessler
JFJessica Faber
Jessica Faber
ILIevgenii Liashenko
Ievgenii Liashenko
NSNatascha Schäfer
Natascha Schäfer
Three‐dimensional (3D) models to study human disease mechanisms have demonstrated that the third dimension is an essential component for neuronal maturation and function. However, 3D neuronal cell culture is challenging due to their ultra‐soft nature and specific extracellular matrix (ECM) organization. This study presents a microfiber reinforcement approach, combining primary mouse spinal cord neurons (SCNs) in a purpose‐adaptable hyaluronic‐acid‐based matrix with melt electrowritten (MEW) frames to study disease mechanisms. The importance of laminins (LNs) is evaluated, which are vital for neuronal adhesion and maturation. Astrocytes (ACs) are mandatory in brain development and function by secretion of signal molecules, maintaining ion homeostasis, clearing of neurotransmitters, and by actively modulating neuronal activity. Three combinations are compared (i) isolated primary SCN, (ii) SCN with ACs (SCN‐AC) and (iii) SCN‐AC and LNs (SCN‐AC‐LN). Multimodal analysis by comparing protein expression, dendrite length, complex mechanical properties, and network functionality via Ca 2+ ‐imaging allows validation of structural and functional neuronal network development. The suitability of the 3D model to study pathomechanisms is demonstrated for Stiff Person Syndrome (SPS). For the first time, functional impairment of spinal cord neurons by patient‐derived autoantibodies characteristic for SPS is recapitulated in a 3D spinal cord model platform adaptable to other disease types.